Compare JANX & ABR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JANX | ABR |
|---|---|---|
| Founded | 2017 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.6B |
| IPO Year | 2021 | 2004 |
| Metric | JANX | ABR |
|---|---|---|
| Price | $14.16 | $7.94 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 6 |
| Target Price | ★ $60.27 | $10.40 |
| AVG Volume (30 Days) | ★ 3.3M | 3.1M |
| Earning Date | 11-06-2025 | 10-31-2025 |
| Dividend Yield | N/A | ★ 15.06% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.80 |
| Revenue | $10,000,000.00 | ★ $552,909,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.86 |
| P/E Ratio | ★ N/A | $10.01 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $13.76 | $7.69 |
| 52 Week High | $61.59 | $14.33 |
| Indicator | JANX | ABR |
|---|---|---|
| Relative Strength Index (RSI) | 28.18 | 31.62 |
| Support Level | $13.82 | $8.76 |
| Resistance Level | $14.49 | $9.30 |
| Average True Range (ATR) | 0.61 | 0.26 |
| MACD | 0.08 | -0.03 |
| Stochastic Oscillator | 9.76 | 14.39 |
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment. The company is externally managed and advised by Arbor Commercial Mortgage, LLC.